Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Gwénaëlle Evanno"'
Autor:
Garyfallia Poulakou, Pierre-Joseph Royer, Nikolay Evgeniev, Gwénaëlle Evanno, Françoise Shneiker, Anne-Geneviève Marcelin, Bernard Vanhove, Odile Duvaux, Stéphane Marot, Vincent Calvez
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionXAV-19 is a glyco-humanized swine polyclonal antibody targeting SARS-CoV-2 with high neutralizing activity. The safety and clinical efficacy of XAV-19 were investigated in patients with mild to moderate COVID-19.MethodsThis phase II/III,
Externí odkaz:
https://doaj.org/article/b72ce91525ff4694b55c65ba81e477f4
Autor:
Bernard Vanhove, Stéphane Marot, Ray T. So, Benjamin Gaborit, Gwénaëlle Evanno, Isabelle Malet, Guillaume Lafrogne, Edwige Mevel, Carine Ciron, Pierre-Joseph Royer, Elsa Lheriteau, François Raffi, Roberto Bruzzone, Chris Ka Pun Mok, Odile Duvaux, Anne-Geneviève Marcelin, Vincent Calvez
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/9918758c1cde4a26875d41b5ad29463f
Autor:
Juliette Rousse, Pierre-Joseph Royer, Gwénaëlle Evanno, Elsa Lheriteau, Carine Ciron, Apolline Salama, Françoise Shneiker, Roberto Duchi, Andrea Perota, Cesare Galli, Emmanuele Cozzi, Gilles Blancho, Odile Duvaux, Sophie Brouard, Jean-Paul Soulillou, Jean-Marie Bach, Bernard Vanhove
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Anti-thymocyte or anti-lymphocyte globulins (ATGs/ALGs) are immunosuppressive drugs used in induction therapies to prevent acute rejection in solid organ transplantation. Because animal-derived, ATGs/ALGs contain highly immunogenic carbohydrate xenoa
Externí odkaz:
https://doaj.org/article/f8566df3328345e5b5b66e10cc962234
Autor:
Bernard Vanhove, Stéphane Marot, Ray T. So, Benjamin Gaborit, Gwénaëlle Evanno, Isabelle Malet, Guillaume Lafrogne, Edwige Mevel, Carine Ciron, Pierre-Joseph Royer, Elsa Lheriteau, François Raffi, Roberto Bruzzone, Chris Ka Pun Mok, Odile Duvaux, Anne-Geneviève Marcelin, Vincent Calvez
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Amino acid substitutions and deletions in the Spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants can reduce the effectiveness of monoclonal antibodies (mAbs). In contrast, heterologous polyclonal antibodies raised
Externí odkaz:
https://doaj.org/article/6f9f8633566c421f939f2280d4799e1e
Autor:
Olivier Reynard, Frédéric Jacquot, Gwénaëlle Evanno, Hoa Le Mai, Apolline Salama, Bernard Martinet, Odile Duvaux, Jean-Marie Bach, Sophie Conchon, Jean-Paul Judor, Andrea Perota, Irina Lagutina, Roberto Duchi, Giovanna Lazzari, Ludmilla Le Berre, Hélène Perreault, Elsa Lheriteau, Hervé Raoul, Viktor Volchkov, Cesare Galli, Jean-Paul Soulillou
Publikováno v:
PLoS ONE, Vol 11, Iss 6, p e0156775 (2016)
Polyclonal xenogenic IgGs, although having been used in the prevention and cure of severe infectious diseases, are highly immunogenic, which may restrict their usage in new applications such as Ebola hemorrhagic fever. IgG glycans display powerful xe
Externí odkaz:
https://doaj.org/article/3c48cfab991749ad839dcf1c00ecbd4f
Autor:
Bernard Vanhove, Stéphane Marot, Gwénaëlle Evanno, Isabelle Malet, Gaëtane Rouvray, Françoise Shneiker, Edwige Mevel, Carine Ciron, Juliette Rousse, Pierre-Joseph Royer, Elsa Lheriteau, François Raffi, Odile Duvaux, Anne-Geneviève Marcelin, Vincent Calvez
Publikováno v:
bioRxiv
B.1.1.529 is the SARS-CoV-2 variant designated Omicron by the WHO in November 2021. It is a highly divergent variant with a high number of mutations, including 26-32 mutations in the spike protein among which 15 in the Receptor Binding Domain (RBD) i
Autor:
Carine Ciron, Marc Bouillet, Sophie Conchon, Roberto Bruzzone, Matthieu Ledure, Ray T.Y. So, Yannick Jacques, Jean-Paul Soulillou, Philippe Delahaut, Apolline Salama, Sophie Brouard, Cesare Galli, Laurent Vacher, Bernard Vanhove, Melody Paulus, Chris Ka Pun Mok, Emanuele Cozzi, Nadine Gervois, Irina Lagutina, Roberto Duchi, Odile Duvaux, Romain Oger, Dominique Blanchard, Pierre-Joseph Royer, Andrea Perota, Jean-Marie Bach, Elsa Lheriteau, Juliette Rousse, Gwénaëlle Evanno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1106719c01e7e108f627299b440c9ea
https://doi.org/10.1002/eji.202049072/v2/response1
https://doi.org/10.1002/eji.202049072/v2/response1
Autor:
Dominique Blanchard, Melody Paulus, Gwénaëlle Evanno, Roberto Bruzzone, Matthieu Ledure, Sophie Brouard, Irina Lagutina, Sophie Conchon, Emanuele Cozzi, Roberto Duchi, Cesare Galli, Juliette Rousse, Bernard Vanhove, Elsa Lheriteau, Laurent Vacher, Apolline Salama, Romain Oger, Pierre-Joseph Royer, Andrea Perota, Nadine Gervois, Marc Bouillet, Yannick Jacques, Odile Duvaux, Ray T.Y. So, Jean-Marie Bach, Jean-Paul Soulillou, Chris Ka Pun Mok, Carine Ciron, Philippe Delahaut
Publikováno v:
European Journal of Immunology
European Journal of Immunology, Wiley-VCH Verlag, 2021, 51 (6), pp.1412-1422. ⟨10.1002/eji.202049072⟩
European Journal of Immunology, 2021, 51 (6), pp.1412-1422. ⟨10.1002/eji.202049072⟩
bioRxiv
European Journal of Immunology, Wiley-VCH Verlag, 2021, 51 (6), pp.1412-1422. ⟨10.1002/eji.202049072⟩
European Journal of Immunology, 2021, 51 (6), pp.1412-1422. ⟨10.1002/eji.202049072⟩
bioRxiv
Heterologous polyclonal antibodies might represent an alternative to the use of convalescent plasma or monoclonal antibodies (mAbs) in coronavirus disease (COVID‐19) by targeting multiple antigen epitopes. However, heterologous antibodies trigger h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4957b696acfecfb00e3d09d6afb3e8a7
http://hdl.handle.net/11577/3378631
http://hdl.handle.net/11577/3378631
Autor:
Gwénaëlle Evanno, Arnaud Nicot, Ludmilla Le Berre, Yohann Foucher, Stéphanie Castagnet, Jean Harb, Pavel Vesely, Sophie Brouard, Ondrej Viklicky, Juliette Rousse, Evelyn Ang, Apolline Salama, Magali Giral, Jean-Marie Bach, Hélène Perreault, Thomas Dejoie, Béatrice Charreau, Petra Hruba, Pierrick Guerif, Grégoire Couvrat-Desvergnes, Jean-Paul Soulillou, Marine Lorent
Publikováno v:
Journal of Clinical Investigation
Journal of Clinical Investigation, 2015, 125 (12), pp.4655-4665. ⟨10.1172/JCI82267⟩
Journal of Clinical Investigation, American Society for Clinical Investigation, 2015, 125 (12), pp.4655-4665. ⟨10.1172/JCI82267⟩
Journal of Clinical Investigation 12 (125), 4655-4665. (2015)
Journal of Clinical Investigation, 2015, 125 (12), pp.4655-4665. ⟨10.1172/JCI82267⟩
Journal of Clinical Investigation, American Society for Clinical Investigation, 2015, 125 (12), pp.4655-4665. ⟨10.1172/JCI82267⟩
Journal of Clinical Investigation 12 (125), 4655-4665. (2015)
Grégoire Couvrat-Desvergnes, Apolline Salama, and Ludmilla Le Berre contributed equally to this work.; International audience; BACKGROUND: Rabbit-generated antithymocyte globulins (ATGs), which target human T cells, are widely used as immunosuppress
Autor:
Gwénaëlle Evanno, Arnaud Nicot, Ludmilla Le Berre, Jean-Paul Soulillou, Juliette Rousse, Noha Lim, Apolline Salama, Stephen E. Gitelman, Mario R. Ehlers, Jean-Marie Bach, Sophie Brouard, Kristina M. Harris
Publikováno v:
Transplantation
Transplantation, 2017, 101 (10), pp.2501-2507. ⟨10.1097/TP.0000000000001686⟩
Transplantation, Lippincott, Williams & Wilkins, 2017, 101 (10), pp.2501-2507. ⟨10.1097/TP.0000000000001686⟩
Transplantation, 2017, 101 (10), pp.2501-2507. ⟨10.1097/TP.0000000000001686⟩
Transplantation, Lippincott, Williams & Wilkins, 2017, 101 (10), pp.2501-2507. ⟨10.1097/TP.0000000000001686⟩
International audience; Background. Polyclonal antihuman thymocyte rabbit IgGs (antithymocyte globulin [ATG]) are popular immunosuppressive drugs used to prevent or treat organ or bone-marrow allograft rejection, graft versus host disease, and autoim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20529587c10145b75b647b633aa81019
https://www.hal.inserm.fr/inserm-02156016
https://www.hal.inserm.fr/inserm-02156016